---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-024943"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:33:36.087514+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vistagen grants 75,000-share options to CEO, CFO, and three other executives at $0.5358

## Summary
- Options granted to five executives: CEO Shawn Singh, CLO Reid Adler, CDO Elissa Cote, COO Joshua Prince, CFO Nick Tressler.
- Each option covers 75,000 shares; exercise price $0.5358 per share.
- Vesting: 25% at 6 months, then 25% every 6 months thereafter, fully vested in 2 years.
- Granted under Amended and Restated 2019 Omnibus Equity Incentive Plan.

## SEC filing metadata
- accession: 0001628280-26-024943
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000162828026024943/0001628280-26-024943-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000162828026024943/vtgn-20260407.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-024943
- JSON: https://secwatch.observer/filing/0001628280-26-024943.json
- Plain text: https://secwatch.observer/filing/0001628280-26-024943.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.